License Agreements (R&D and Journey) (Details) - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Apr. 30, 2024 |
Jun. 30, 2021 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| License Agreements | |||||||
| Expense recognized for licenses acquired | $ 0.0 | $ 0.0 | $ 0.0 | $ 0.0 | |||
| Journey | Emrosi Agreement | |||||||
| License Agreements | |||||||
| Upfront fees paid | $ 10.0 | ||||||
| Milestone paid | $ 15.0 | $ 3.0 | |||||
| Minimum | Journey | Emrosi Agreement | |||||||
| License Agreements | |||||||
| Percentage of royalty on future net sales | 10.00% | ||||||
| Maximum | Journey | Emrosi Agreement | |||||||
| License Agreements | |||||||
| Additional milestones payable | $ 150.0 | ||||||
| Percentage of royalty on future net sales | 14.00% | ||||||
| X | ||||||||||
- Definition Amount of milestone paid No definition available.
|
| X | ||||||||||
- Definition Amount of additional milestones payable under the agreement. No definition available.
|
| X | ||||||||||
- Definition Payment of Upfront Fees No definition available.
|
| X | ||||||||||
- Definition Percentage of royalty on future net sales granted to the company. No definition available.
|
| X | ||||||||||
- Definition The amount of costs incurred under a research and development arrangement accounted for as a contract to perform research and development for others. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|